Corvus Pharmaceuticals, Inc.
CRVSNASDAQNASDAQ Global Market·USD·Closed
$20.70
−$0.24 (1.15%)
$20.70
−$0.24 (1.15%)
Not investment advice.Learn more
CRVS has more going for it than against it right now.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Mid-range
Volume
Market Cap
Small-cap company
P/E Ratio
Div Yield
No dividend